(19)
(11) EP 3 237 018 A1

(12)

(43) Date of publication:
01.11.2017 Bulletin 2017/44

(21) Application number: 15873796.5

(22) Date of filing: 23.12.2015
(51) International Patent Classification (IPC): 
A61K 48/00(2006.01)
(86) International application number:
PCT/US2015/000269
(87) International publication number:
WO 2016/105516 (30.06.2016 Gazette 2016/26)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 26.12.2014 US 201462097012 P
30.09.2015 US 201562235269 P

(71) Applicant: Celgene Alpine Investment Company II, LLC
HM 08 Pembroke (BM)

(72) Inventors:
  • SMITH, Scott, Andrew
    Oldwick, NJ 08858 (US)
  • LI, Xiaobin
    Belle Mead, NJ 08502 (US)
  • ROSSITER, Guillermo
    Ramsey, NJ 07446 (US)
  • MARTIN, Philippe, L.
    Hoboken, NJ 07030 (US)
  • DEWACKER, Seth, R.
    Bridgewater, NJ 08807 (US)
  • USISKIN, Keith
    Mendham, NJ 07945 (US)
  • CLINE, Gary, Allan
    Basking Ridge, NJ 07920 (US)

(74) Representative: Jones Day 
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11
80538 München
80538 München (DE)

   


(54) METHODS OF USING SMAD7 ANTISENSE OLIGONUCLEOTIDES